Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for PRTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 15.50M
March 31, 2026 6.946M
December 31, 2025 0.1434M
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.048M
December 31, 2024 0.098M
September 30, 2024 -0.355M
June 30, 2024 -0.4389M
March 31, 2024 -0.836M
December 31, 2023 -2.924M
September 30, 2023 -2.785M
June 30, 2023 -15.87M
March 31, 2023 -23.28M
December 31, 2022 -228.50M
September 30, 2022 -3.985M
June 30, 2022 -0.3779M
March 31, 2022 -1.488M
December 31, 2021 1.466M
September 30, 2021 -83.93M
June 30, 2021 -20.27M
March 31, 2021 -81.33M
December 31, 2020 -0.0009M
September 30, 2020 -0.0729M
June 30, 2020 0.00
Date Value
March 31, 2020 -0.151M
December 31, 2019 -0.013M
September 30, 2019 0.0014M
June 30, 2019 -0.2089M
March 31, 2019 -0.005M
December 31, 2018 0.3666M
September 30, 2018 0.2021M
June 30, 2018 0.5824M
March 31, 2018 -44.14M
December 31, 2017 0.4411M
September 30, 2017 -10.92M
June 30, 2017 -4.676M
March 31, 2017 -160.37M
December 31, 2016 -4.170M
September 30, 2016 -0.242M
June 30, 2016 -2.325M
March 31, 2016 -128.96M
December 31, 2015 -1.781M
September 30, 2015 -0.7463M
June 30, 2015 -132.05M
March 31, 2015 -0.636M
December 31, 2014 4.132M
September 30, 2014 -11.90M
June 30, 2014 -102.91M
March 31, 2014 -0.30M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Alkermes Plc 1.485B
Amarin Corp. Plc -0.059M
Agenus, Inc. -14.71M
Amgen, Inc. 0.00
Anika Therapeutics, Inc. 0.643M